EASL clinical practice guidelines: management of hepatocellular carcinoma
Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-
related death globally. Hepatocellular carcinoma represents about 90% of primary liver …
related death globally. Hepatocellular carcinoma represents about 90% of primary liver …
Epidemiology and surveillance for hepatocellular carcinoma: New trends
AG Singal, P Lampertico, P Nahon - Journal of hepatology, 2020 - Elsevier
The burden of hepatocellular carcinoma (HCC) is highest in East Asia and Africa, although
its incidence and mortality are rapidly rising in the United States and Europe. With the …
its incidence and mortality are rapidly rising in the United States and Europe. With the …
Cancer statistics, 2018
Abstract Each year, the American Cancer Society estimates the numbers of new cancer
cases and deaths that will occur in the United States and compiles the most recent data on …
cases and deaths that will occur in the United States and compiles the most recent data on …
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
H Yoshiji, S Nagoshi, T Akahane, Y Asaoka… - Journal of …, 2021 - Springer
The first edition of the clinical practice guidelines for liver cirrhosis was published in 2010,
and the second edition was published in 2015 by the Japanese Society of Gastroenterology …
and the second edition was published in 2015 by the Japanese Society of Gastroenterology …
Hepatocellular carcinoma: a review
J Balogh, D Victor III, EH Asham… - Journal of …, 2016 - Taylor & Francis
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is a
leading cause of cancer-related death worldwide. In the United States, HCC is the ninth …
leading cause of cancer-related death worldwide. In the United States, HCC is the ninth …
[PDF][PDF] Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America recommendations for testing …
MG Ghany, TR Morgan… - …, 2020 - Wiley Online Library
HCV infection, risk-based screening failed to identify the majority of individuals with HCV
infection due to both clinician and patient barriers.(9-12) Analysis of the 2003-2010 National …
infection due to both clinician and patient barriers.(9-12) Analysis of the 2003-2010 National …
EASL recommendations on treatment of hepatitis C 2016
European Association for The Study of The Liver - Journal of hepatology, 2017 - Elsevier
Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease
worldwide [1]. The long-term impact of HCV infection is highly variable, ranging from minimal …
worldwide [1]. The long-term impact of HCV infection is highly variable, ranging from minimal …
Annual Report to the Nation on the Status of Cancer, 1975‐2012, featuring the increasing incidence of liver cancer
AB Ryerson, CR Eheman, SF Altekruse, JW Ward… - Cancer, 2016 - Wiley Online Library
BACKGROUND Annual updates on cancer occurrence and trends in the United States are
provided through an ongoing collaboration among the American Cancer Society (ACS), the …
provided through an ongoing collaboration among the American Cancer Society (ACS), the …
[HTML][HTML] Natural history of hepatitis C
RH Westbrook, G Dusheiko - Journal of hepatology, 2014 - Elsevier
There has long been evidence that hepatitis C can lead to persistent infection in a high
proportion of infected individuals, and can progress to chronic liver disease, cirrhosis and …
proportion of infected individuals, and can progress to chronic liver disease, cirrhosis and …
[HTML][HTML] EASL recommendations on treatment of hepatitis C 2015
European Association For The Study Of The Liver - Journal of hepatology, 2015 - Elsevier
Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease
worldwide [1]. The long-term impact of HCV infection is highly variable, ranging from minimal …
worldwide [1]. The long-term impact of HCV infection is highly variable, ranging from minimal …